SG10201807204YA - Oral formulations of deferasirox - Google Patents
Oral formulations of deferasiroxInfo
- Publication number
- SG10201807204YA SG10201807204YA SG10201807204YA SG10201807204YA SG10201807204YA SG 10201807204Y A SG10201807204Y A SG 10201807204YA SG 10201807204Y A SG10201807204Y A SG 10201807204YA SG 10201807204Y A SG10201807204Y A SG 10201807204YA SG 10201807204Y A SG10201807204Y A SG 10201807204YA
- Authority
- SG
- Singapore
- Prior art keywords
- deferasirox
- oral formulations
- formulations
- neutral
- suitables
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Botany (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
ORAL FORMULATIONS OF DEFERASIROX Orally administerable deferasirox formulations are disclosed having reduced release under gastric conditions and fast release at near neutral pH or at neutral pH. No suitables figures
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361774893P | 2013-03-08 | 2013-03-08 | |
US201361824435P | 2013-05-17 | 2013-05-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201807204YA true SG10201807204YA (en) | 2018-09-27 |
Family
ID=50288212
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201506491RA SG11201506491RA (en) | 2013-03-08 | 2014-03-06 | Oral formulations of deferasirox |
SG10201807204YA SG10201807204YA (en) | 2013-03-08 | 2014-03-06 | Oral formulations of deferasirox |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201506491RA SG11201506491RA (en) | 2013-03-08 | 2014-03-06 | Oral formulations of deferasirox |
Country Status (42)
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT2964202T (en) | 2013-03-08 | 2019-02-11 | Novartis Ag | Oral formulations of deferasirox |
US9866684B2 (en) * | 2015-02-16 | 2018-01-09 | Microsoft Technology Licensing, Llc | Process for real-time data exchange between users on a phone call |
WO2016167729A1 (en) * | 2015-04-16 | 2016-10-20 | Öğün Yusuf Toktamiş | Dispersible tablets comprising deferasirox |
CN107847490A (en) * | 2015-06-17 | 2018-03-27 | 分散技术有限责任公司 | Improved DEFERASIROX preparation and the method for preparing it |
US20190091204A1 (en) | 2016-03-17 | 2019-03-28 | Lupin Limited | Compositions of deferasirox |
CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
EP3481390A4 (en) * | 2016-07-05 | 2020-03-04 | Jubilant Generics Limited | Immediate release pharmaceutical composition of iron chelating agents |
EP3518904A1 (en) | 2016-09-30 | 2019-08-07 | Synthon B.V. | Pharmaceutical composition comprising deferasirox |
CZ2017255A3 (en) * | 2017-05-04 | 2018-11-14 | Zentiva, K.S. | Film-coated Deferasirox tablets |
TR201707764A2 (en) * | 2017-05-29 | 2018-12-21 | Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi | Split tablet forms of deferasirox. |
WO2019108156A1 (en) * | 2017-11-28 | 2019-06-06 | Biofarma Ilac Sanayi Ve Ticaret A.S. | A scored tablet formulation comprising deferasirox in a film tablet form |
KR20200113116A (en) | 2019-03-22 | 2020-10-06 | 주식회사 한국팜비오 | A film-coated tablet comprising deferasirox |
EP4052698A1 (en) * | 2021-03-05 | 2022-09-07 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Film coated tablet comprising deferasirox |
CN115154428B (en) * | 2022-09-06 | 2023-01-10 | 上海奥科达医药科技股份有限公司 | Deferasirox pharmaceutical composition and preparation method thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW533205B (en) * | 1996-06-25 | 2003-05-21 | Novartis Ag | Substituted 3,5-diphenyl-l,2,4-triazoles and their pharmaceutical composition |
GB0223978D0 (en) * | 2002-10-15 | 2002-11-20 | Novartis Ag | Organic compound |
KR20070022243A (en) * | 2004-04-08 | 2007-02-26 | 노파르티스 아게 | Deferasirox dispersible tablets |
GB0408078D0 (en) * | 2004-04-08 | 2004-05-12 | Novartis Ag | Organic compounds |
WO2007045445A1 (en) * | 2005-10-19 | 2007-04-26 | Novartis Ag | Dispersible tablets comprising deferasirox |
EP2062572A1 (en) | 2007-11-19 | 2009-05-27 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical compositions |
WO2009106824A2 (en) | 2008-02-25 | 2009-09-03 | Cipla Limited | Pharmaceutical formulations |
WO2009130604A2 (en) | 2008-04-21 | 2009-10-29 | Actavis Group Ptc Ehf | Solid state forms of deferasirox salts and process for the preparation thereof |
WO2010035282A1 (en) | 2008-09-24 | 2010-04-01 | Matrix Laboratories Limited | Pharmaceutical compositions comprising deferasirox |
WO2010143006A1 (en) * | 2009-06-10 | 2010-12-16 | Carlo Ghisalberti | Orally bioavailable iron chelators in the treatment of an inflammatory bowel disease |
WO2012003987A1 (en) * | 2010-07-08 | 2012-01-12 | Ratiopharm Gmbh | Oral dosage form of deferasirox |
MY165826A (en) * | 2010-10-01 | 2018-05-17 | Cipla Ltd | Pharmaceutical composition |
LT2964202T (en) | 2013-03-08 | 2019-02-11 | Novartis Ag | Oral formulations of deferasirox |
US20190091204A1 (en) | 2016-03-17 | 2019-03-28 | Lupin Limited | Compositions of deferasirox |
-
2014
- 2014-03-06 LT LTEP14710654.6T patent/LT2964202T/en unknown
- 2014-03-06 CA CA2890465A patent/CA2890465A1/en not_active Abandoned
- 2014-03-06 KR KR1020177010591A patent/KR20170045391A/en not_active Application Discontinuation
- 2014-03-06 DK DK14710654.6T patent/DK2964202T3/en active
- 2014-03-06 BR BR112015021254A patent/BR112015021254A2/en not_active IP Right Cessation
- 2014-03-06 SI SI201430621T patent/SI3124018T1/en unknown
- 2014-03-06 MY MYPI2015702695A patent/MY170303A/en unknown
- 2014-03-06 PE PE2015001870A patent/PE20151600A1/en unknown
- 2014-03-06 SG SG11201506491RA patent/SG11201506491RA/en unknown
- 2014-03-06 UY UY0001035367A patent/UY35367A/en not_active Application Discontinuation
- 2014-03-06 SI SI201431064T patent/SI2964202T1/en unknown
- 2014-03-06 HU HUE16188627A patent/HUE036921T2/en unknown
- 2014-03-06 CN CN201480012815.XA patent/CN105025886B/en active Active
- 2014-03-06 SG SG10201807204YA patent/SG10201807204YA/en unknown
- 2014-03-06 PT PT161886270T patent/PT3124018T/en unknown
- 2014-03-06 ES ES16188627.0T patent/ES2663135T3/en active Active
- 2014-03-06 MX MX2015011962A patent/MX361055B/en active IP Right Grant
- 2014-03-06 DK DK16188627.0T patent/DK3124018T3/en active
- 2014-03-06 AU AU2014224198A patent/AU2014224198B2/en active Active
- 2014-03-06 PL PL16188627T patent/PL3124018T3/en unknown
- 2014-03-06 RS RS20180167A patent/RS56890B1/en unknown
- 2014-03-06 EP EP14710654.6A patent/EP2964202B2/en active Active
- 2014-03-06 CU CUP2015000110A patent/CU24348B1/en unknown
- 2014-03-06 EA EA201591665A patent/EA031719B1/en not_active IP Right Cessation
- 2014-03-06 TW TW103107731A patent/TWI625136B/en active
- 2014-03-06 RS RS20190142A patent/RS58317B1/en unknown
- 2014-03-06 KR KR1020157027470A patent/KR101925671B1/en active IP Right Grant
- 2014-03-06 ME MEP-2019-30A patent/ME03297B/en unknown
- 2014-03-06 LT LTEP16188627.0T patent/LT3124018T/en unknown
- 2014-03-06 ES ES14710654T patent/ES2708955T5/en active Active
- 2014-03-06 US US14/198,872 patent/US9283209B2/en active Active
- 2014-03-06 HU HUE14710654A patent/HUE041224T2/en unknown
- 2014-03-06 WO PCT/IB2014/059494 patent/WO2014136079A1/en active Application Filing
- 2014-03-06 TW TW107112193A patent/TWI686215B/en active
- 2014-03-06 JP JP2015560837A patent/JP6434429B2/en active Active
- 2014-03-06 EP EP16188627.0A patent/EP3124018B2/en active Active
- 2014-03-06 JO JOP/2014/0075A patent/JO3570B1/en active
- 2014-03-06 PL PL14710654T patent/PL2964202T3/en unknown
- 2014-03-06 NZ NZ711179A patent/NZ711179A/en unknown
- 2014-03-06 AP AP2015008668A patent/AP2015008668A0/en unknown
- 2014-03-06 PT PT14710654T patent/PT2964202T/en unknown
-
2015
- 2015-05-12 SA SA515360425A patent/SA515360425B1/en unknown
- 2015-08-20 ZA ZA2015/06060A patent/ZA201506060B/en unknown
- 2015-08-24 IL IL240797A patent/IL240797B/en unknown
- 2015-09-04 TN TN2015000393A patent/TN2015000393A1/en unknown
- 2015-09-07 PH PH12015501981A patent/PH12015501981A1/en unknown
- 2015-09-07 NI NI201500126A patent/NI201500126A/en unknown
- 2015-09-07 CL CL2015002495A patent/CL2015002495A1/en unknown
- 2015-09-08 CR CR20150467A patent/CR20150467A/en unknown
- 2015-09-08 DO DO2015000220A patent/DOP2015000220A/en unknown
- 2015-10-08 EC ECIEPI201542897A patent/ECSP15042897A/en unknown
-
2016
- 2016-01-13 HK HK16100339.2A patent/HK1212242A1/en active IP Right Maintenance
- 2016-02-05 US US15/017,084 patent/US20160220493A1/en not_active Abandoned
-
2017
- 2017-06-08 AU AU2017203897A patent/AU2017203897B2/en active Active
- 2017-06-16 US US15/625,863 patent/US20170290811A1/en not_active Abandoned
-
2018
- 2018-03-06 HR HRP20180387TT patent/HRP20180387T1/en unknown
- 2018-03-12 CY CY20181100302T patent/CY1120021T1/en unknown
- 2018-03-23 US US15/934,595 patent/US20180221285A1/en not_active Abandoned
- 2018-05-24 JP JP2018099612A patent/JP6739470B2/en active Active
-
2019
- 2019-01-25 HR HRP20190173TT patent/HRP20190173T1/en unknown
- 2019-01-31 CY CY20191100143T patent/CY1121315T1/en unknown
-
2020
- 2020-06-08 JP JP2020099402A patent/JP2020180123A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201807204YA (en) | Oral formulations of deferasirox | |
IL249051A0 (en) | Aural measurements from earphone output speakers | |
HK1258095A1 (en) | C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses | |
DK3319339T3 (en) | BINAURAL HEARING SYSTEM AND PROCEDURE | |
EP3268125A4 (en) | Determination of cells using amplification | |
EP3280398A4 (en) | Self-emulsifying formulations of dim-related indoles | |
EP3305256A4 (en) | Hygienic protector for male urination | |
EP3305255A4 (en) | Vest-type maternity belt | |
ITUB20153699A1 (en) | ORAL SUPPLEMENT | |
PL3467444T3 (en) | Watertightness of sensors | |
AU2017901767A0 (en) | An improved male undergarment | |
AU2016904714A0 (en) | An improved male undergarment | |
UA103911U (en) | Vasodilating substance | |
GB201502208D0 (en) | Hear my language- I'm listening |